Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel platelet antiaggregating substances.

D Reynaud1, A Sun, P Demin

  • 1Research Institute, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada.

Biochemical and Biophysical Research Communications
|June 9, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Copper-catalyzed three-component thiocyanosulfonylation of allenes.

Chemical communications (Cambridge, England)·2026
Same author

Toxicological Evaluation of Vanillin Flavor in E-Liquid Aerosols on Endothelial Cell Function: Findings from the Replica Project.

Cardiovascular toxicology·2026
Same author

New Measurements of the Deuteron-to-Proton F_{2} Structure-Function Ratio.

Physical review letters·2025
Same author

Optimization of carotid CT angiography image quality with deep learning image reconstruction with high setting (DLIR-H) algorithm under ultra-low radiation and contrast agent conditions.

Radiography (London, England : 1995)·2025
Same author

Potential Drug Dose-Specific Adverse Three-Drug Combinations: A US Insurance Claims Data-Based Study.

Pharmacoepidemiology and drug safety·2025
Same author

Comparison of perfusion defects parameters in dual-energy computed tomography (CT) pulmonary angiography across arterial phase and venous phase.

Clinical radiology·2025
Same journal

Quercetin suppresses TGF-β1-induced proliferation and migration of vascular smooth muscle cells via the Smad2/3/MMP-9 signaling axis.

Biochemical and biophysical research communications·2026
Same journal

Biosynthesis, characterization and biological potential of microbe-mediated silver nanoparticles using thermophilic actinomycetes, Streptomyces nigra.

Biochemical and biophysical research communications·2026
Same journal

COP9 signalosome 8 mediated autophagy drives proliferation, invasion, and metastasis in pancreatic ductal adenocarcinoma.

Biochemical and biophysical research communications·2026
Same journal

Tumor budding in colorectal cancer: partial EMT, microenvironmental remodeling, and metastatic competence.

Biochemical and biophysical research communications·2026
Same journal

Exploring the therapeutic versatility and multitarget pharmacological potential of acyl hydrazone-hydrazide scaffolds.

Biochemical and biophysical research communications·2026
Same journal

The plasma membrane H<sup>+</sup>-ATPase OSA2 negatively regulates salt tolerance in rice seedlings.

Biochemical and biophysical research communications·2026
See all related articles

Novel hepoxilin analogs potently inhibit human platelet aggregation and thromboxane A(2) formation. These compounds show promise for treating cardiovascular diseases linked to thromboxane.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cardiovascular Research

Background:

  • Hepoxilins are biologically active lipid mediators.
  • Platelet aggregation is a key process in cardiovascular disease.
  • Existing treatments for cardiovascular disease have limitations.

Purpose of the Study:

  • To investigate the anti-platelet activity of novel stable hepoxilin analogs.
  • To determine the mechanism of action of these analogs.
  • To evaluate their potential therapeutic applications in cardiovascular disease.

Main Methods:

  • Synthesis and characterization of four stable hepoxilin analogs.
  • Inhibition assays for collagen-evoked human platelet aggregation.
  • Measurement of thromboxane A(2), HHT, 12-HETE, and arachidonic acid formation.

Related Experiment Videos

  • Determination of IC(50) values for analog activity.

    • Main Results:

    • All four analogs inhibited collagen-induced platelet aggregation.
    • One analog, PBT-3, demonstrated significant potency (IC(50) = 8 x 10(-7) M).
    • Analogs were approximately 500-fold more potent than native hepoxilins and inhibited thromboxane A(2) and HHT formation without affecting 12-HETE or arachidonic acid release at effective doses.

    Conclusions:

    • Novel stable hepoxilin analogs exhibit potent anti-platelet activity.
    • These compounds selectively inhibit thromboxane A(2) synthesis.
    • The findings suggest potential for developing these analogs into therapeutics for thromboxane-mediated cardiovascular diseases.